Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CytomX Therapeutics, Inc. | Chief Business Officer | Common Stock | 119K | $146K | $1.23 | Aug 20, 2024 | Direct |
CytomX Therapeutics, Inc. | Chief Business Officer | Common Stock | 4.5K | $5.53K | $1.23 | Aug 20, 2024 | Fidelity Traditional IRA |
CytomX Therapeutics, Inc. | Chief Business Officer | Common Stock | 3.18K | $3.91K | $1.23 | Aug 20, 2024 | Schwab ROTH IRA |
CytomX Therapeutics, Inc. | Chief Business Officer | Performance Stock Units (PSUs) | 0 | $0 | $1.23 | Aug 20, 2024 | Direct |
CytomX Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 140K | Jan 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTMX | CytomX Therapeutics, Inc. | Aug 20, 2024 | 3 | -$5.14K | 4 | Aug 22, 2024 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Mar 19, 2024 | 1 | -$13.7K | 4 | Mar 21, 2024 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Jan 18, 2024 | 3 | $0 | 4 | Jan 19, 2024 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Dec 20, 2023 | 1 | -$5.63K | 4 | Dec 22, 2023 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Dec 17, 2023 | 2 | $0 | 4 | Dec 19, 2023 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Sep 20, 2023 | 2 | -$5.36K | 4 | Sep 22, 2023 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Mar 16, 2023 | 1 | -$2.92K | 4 | Mar 20, 2023 | Chief Financial Officer |
CTMX | CytomX Therapeutics, Inc. | Feb 2, 2023 | 3 | $0 | 4 | Feb 6, 2023 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Aug 10, 2022 | 2 | $0 | 4 | Aug 12, 2022 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Jul 19, 2022 | 2 | -$5.98K | 4 | Jul 21, 2022 | Chief Business Officer |
CTMX | CytomX Therapeutics, Inc. | Mar 23, 2022 | 0 | $0 | 3 | Mar 28, 2022 | Chief Business Officer |